| FLORIDA                                                                      | 11-3331350                                          |
|------------------------------------------------------------------------------|-----------------------------------------------------|
| (State                or other jurisdiction of incorporation ororganization) | (I.R.S.                Employer Identification No.) |

----

| UniverCell                Holdings, Inc.(A                Development Stage Company) |
|--------------------------------------------------------------------------------------|
| Consolidated                Balance Sheets                                           |
| (Unaudited)                                                                          |

|                                    |   | June                    30, |   | December                    31, |   |
|-----------------------------------------|--------|-----------------------------|--------|---------------------------------|--------|
|                                    |   | 2007                        |   | 2006                            |   |
|                                    |   | (Unaudited)                 |   |                            |   |
| ASSETS                                  |   |
| Current                    Assets       |   |                        |   |                            |   |
| Cash                                    |   | $                           | 0      |                            | $      | 0 |   |
|                                    |   |                        |   |                            |   |   |   |
| Total                    Current Assets |   | $                           | 0      |                            | $      | 0 |   |

|                                                                                                                                                      |   | June                    30, |       | December                    31, |   |
|-----------------------------------------------------------------------------------------------------------------------------------------------------------|--------|-----------------------------|------------|---------------------------------|--------|
|                                                                                                                                                      |   | 2007                        |       | 2006                            |   |
|                                                                                                                                                      |   | (Unaudited)                 |       |                            |   |
| LIABILITIES                    AND STOCKHOLDERS' EQUITY                                                                                                   |   |
| Current                    Liabilities                                                                                                                    |   |                        |       |                            |   |
| Accounts                    Payable                                                                                                                       |   | $                           | 12,357     |                            | $      | 13,297 |   |
| Accrued                    Expenses                                                                                                                       |   |                        | 198,995    |                            |   | 198,995 |   |
| Notes                    Payable –                    Related                    Party                                                         |   |                        | 267,778    |                            |   | 262,778 |   |
|                                                                                                                                                      |   |                        |       |                            |   |   |   |
| Total                    Current Liabilities                                                                                                              |   |                        | 479,130    |                            |   | 475,070 |   |
|                                                                                                                                                      |   |                        |       |                            |   |   |   |
| Stockholders'                    Equity                                                                                                                   |   |                        |       |                            |   |   |   |
| Common                    Stock, Authorized 200,000,000 Shares, $.0001Par Value, Issued                    and                    Outstanding 199,250,000 |   |                        |       |                            |   |   |   |
|                                                                                                                                                      |   |                        | 19,925     |                            |   | 19,925 |   |
| Additional                    Paid in Capital                                                                                                             |   |                        | 1,305,380  |                            |   | 1,305,380 |   |
| Retained                    Earnings (Deficit)                                                                                                            |   |                        | (1,804,435 | )                               |   | (1,800,376 | ) |
|                                                                                                                                                      |   |                        |       |                            |   |   |   |
| Total                    Stockholders' Equity                                                                                                             |   |                        | (479,130   | )                               |   | (475,070 | ) |
|                                                                                                                                                      |   |                        |       |                            |   |   |   |
| 1                    Total Liabilities and Stockholders' Equity                                                                                           |   | $                           | 0          |                            | $      | 0 |   |

----

| UniverCell                Holdings, Inc.(A                Development Stage Company) |
|--------------------------------------------------------------------------------------|
| Consolidated                Statements of Operations                                 |
| (Unaudited)                                                                          |

|                                                                                             |   | For                the Three Months Ended |        | For                the Six Months Ended |   |
|--------------------------------------------------------------------------------------------------|--------|-------------------------------------------|-------------|-----------------------------------------|--------|
|                                                                                             |   | June                30,                   |        | June                30,                 |   |
|                                                                                             |   | 2007                                      |        | 2006                                    |   | 2007 |   | 2006 |   |
|                                                                                             |   |                                      |        |                                    |   |   |   |   |   |
| Revenues                                                                                         |   | $                                         | -           |                                    | $      | - |   | $ | - |   | $ | - |   |
|                                                                                             |   |                                      |        |                                    |   |   |   |   |   |   |   |   |   |
| Cost                of Sales                                                                     |   |                                      | -           |                                    |   | - |   |   | - |   |   | - |   |
|                                                                                             |   |                                      |        |                                    |   |   |   |   |   |   |   |   |   |
| Gross                Profit (Loss)                                                               |   |                                      | -           |                                    |   | - |   |   | - |   |   | - |   |
|                                                                                             |   |                                      |        |                                    |   |   |   |   |   |   |   |   |   |
| Operating                Expenses                                                                |   |                                      |        |                                    |   |   |   |   |   |   |   |   |   |
| General                & Administrative                                                      |   |                                      | 3,484       |                                    |   | 74,232 |   |   | 4,059 |   |   | 136,809 |   |
|                                                                                             |   |                                      |        |                                    |   |   |   |   |   |   |   |   |   |
| Total                Operating Expenses                                                          |   |                                      | 3,484       |                                    |   | 74,232 |   |   | 4,059 |   |   | 136,809 |   |
|                                                                                             |   |                                      |        |                                    |   |   |   |   |   |   |   |   |   |
| Net                Operating Income (Loss) from continuing Operations                            |   |                                      | (3,484      | )                                       |   | (74,232 | ) |   | (4,059 | ) |   | (136,809 | ) |
|                                                                                             |   |                                      |        |                                    |   |   |   |   |   |   |   |   |   |
| Other                Income (Expense)                                                            |   |                                      | -           |                                    |   | - |   |   | - |   |   | - |   |
| Interest                Income                                                                   |   |                                      | -           |                                    |   | - |   |   | - |   |   | - |   |
| Interest                Expense                                                                  |   |                                      | -           |                                    |   | - |   |   | - |   |   | - |   |
| Loss                before provision for income taxes and discontinued                operations |   |                                      | (3,484      | )                                       |   | (74,232 | ) |   | (4,059 | ) |   | (136,809 | ) |
| Provision                for Income Taxes                                                        |   |                                      | -           |                                    |   | - |   |   |   |   |   | - |   |
|                                                                                             |   |                                      |        |                                    |   |   |   |   |   |   |   |   |   |
| Loss                from continuing operations before discontinued operations                    |   |                                      | (3,484      | )                                       |   | (74,232 | ) |   | (4,059 | ) |   | (136,809 | ) |
| Gain                (Loss) on disposal of Discontinued operations (net of                taxes)  |   |                                      | -           |                                    |   | - |   |   | - |   |   | - |   |
|                                                                                             |   |                                      |        |                                    |   |   |   |   |   |   |   |   |   |
| Net                Income (Loss)                                                                 |   |                                      | (3,484      | )                                       |   | (74,232 | ) |   | (4,059 | ) |   | (136,809 | ) |
|                                                                                             |   |                                      |        |                                    |   |   |   |   |   |   |   |   |   |
| Net                Income (Loss) Per share for continuing operations                             |   | $                                         | (0.00       | )                                       | $      | (0.00 | ) | $ | (0.00 | ) | $ | (0.00 | ) |
|                                                                                             |   |                                      |        |                                    |   |   |   |   |   |   |   |   |   |
| Net                Income (Loss) Per Share for discontinued operations                           |   | $                                         | (0.00       | )                                       | $      | (0.00 | ) | $ | (0.00 | ) | $ | (0.00 | ) |
|                                                                                             |   |                                      |        |                                    |   |   |   |   |   |   |   |   |   |
| Weighted                Average Shares Outstanding                                               |   |                                      | 199,250,000 |                                    |   | 199,250,000 |   |   | 199,250,000 |   |   | 199,250,000 |   |

----

| UniverCell                Holdings, Inc.(A                Development Stage Company) |
|--------------------------------------------------------------------------------------|
| Consolidated                Statements of Cash Flows                                 |
|  (Unaudited)                                                                    |

|                                                                                                        |   | For                    the six months ended |   |
|-------------------------------------------------------------------------------------------------------------|--------|---------------------------------------------|--------|
|                                                                                                        |   | June                    30,                 |   |
|                                                                                                        |   | 2007                                        |   | 2006 |   |
|                                                                                                        |   |                                        |   |   |   |
| CASH                    FLOWS FROM OPERATING ACTIVITIES:                                                    |   |                                        |   |   |   |
|                                                                                                        |   |                                        |   |   |   |
| Net                    Income (Loss)                                                                        |   | $                                           | (4,059 | ) | $ | 218,910 |   |
| Adjustments                    to Reconcile Net Loss to Net Cash Provided                    by Operations: |   |                                        |   |   |   |   |   |
| Increase                    (Decrease) in Notes Payable                                                     |   |                                        | 5,000  |   |   | 261,192 |   |
| Loss                    (Gain) on sale of subsidiary                                                        |   |                                        | -      |   |   | - |   |
| Change                    in Assets and Liabilities                                                         |   |                                        |   |   |   |   |   |
| Increase                    (Decrease) in Accounts Payable/ Accrued Expenses                                |   |                                        | 4,059  |   |   | (126,813 | ) |
|                                                                                                        |   |                                        |   |   |   |   |   |
| Net                    Cash Provided(Used) by Operating Activities                                          |   |                                        | 0      |   |   | (2,430 | ) |
|                                                                                                        |   |                                        |   |   |   |   |   |
| CASH                    FLOWS FROM INVESTING ACTIVITIES:                                                    |   |                                        |   |   |   |   |   |
| Proceeds                    from sale of subsidiary                                                         |   |                                        | -      |   |   | - |   |
| Cash                    Balance transferred in sale                                                         |   |                                        | -      |   |   | - |   |
|                                                                                                        |   |                                        |   |   |   |   |   |
| Net                    Cash Provided (Used) by Investing Activities                                         |   |                                        |   |   |   |   |   |
|                                                                                                        |   |                                        |   |   |   |   |   |
| Net                    Cash Provided (Used) by Discontinuing Operations                                     |   |                                        |   |   |   |   |   |
|                                                                                                        |   |                                        |   |   |   |   |   |
| NET                    INCREASE (DECREASE) IN CASH AND EQUIVALENTS                                          |   |                                        | 0      |   |   | (2,430 | ) |
|                                                                                                        |   |                                        |   |   |   |   |   |
| CASH                    AND EQUIVALENTS AT BEGINNING OF PERIOD                                              |   |                                        | 0      |   |   | 2,530 |   |
|                                                                                                        |   |                                        |   |   |   |   |   |
| CASH                    AND CASH EQUIVALENTS AT END OF PERIOD                                               |   | $                                           | 0      |   | $ | 100 |   |

| The                    accompanying notes are an integral part of theses financial                    statements. |
|-------------------------------------------------------------------------------------------------------------------|

----

| UniverCell                Holdings, Inc.(A                Development Stage Company) |
|--------------------------------------------------------------------------------------|
| Consolidated                Statements of Cash Flows                (Continued)      |

|                                                  |   | For                  the six months endedJune                  30, |   |
|-------------------------------------------------------|--------|--------------------------------------------------------------------|--------|
|                                                  |   | 2007                                                               |   | 2006 |   |
| Cash                  Paid For:                       |   |                                                               |   |   |   |
| Interest                                              |   |                                                               |   |   |   |
| Taxes                                                 |   | $                                                                  | -      |   | $ | - |   |
|                                                  |   |                                                               |   |   |   |   |   |
| Non-Cash                  Activities:                 |   |                                                               |   |   |   |   |   |
| Shares                  Issued for Services           |   |                                                               | -      |   |   |  |   |
| Note                  issued in exchange for payables |   | $                                                                  | 0      |   | $ | 261,192 |   |

| The                accompanying notes are an integral part of these financial                statements. |
|----------------------------------------------------------------------------------------------------------|

----

----

| ·   | general                economic and business conditions; |
|--------------------|----------------------------------------------------------|

| ·   | our                ability to implement our business                strategy; |
|--------------------|-------------------------------------------------------------------------------|

| ·   | our                access to financing; |
|--------------------|-----------------------------------------|

| ·   | our                ability to successfully identify new business                opportunities; |
|--------------------|------------------------------------------------------------------------------------------------|

| ·   | our                ability to attract and retain key                executives; |
|--------------------|---------------------------------------------------------------------------------|

| ·   | the                effect of regulatory and legal                restrictions. |
|--------------------|--------------------------------------------------------------------------------|

----

|   | 31.1 | Certification                of Principal Executive Officer - - Rule 13a-14(a)                Certification |
|--------|------|-------------------------------------------------------------------------------------------------------------|
|   |   |   |
|--------|--------|--------|
|   | 31.2 | Certification                of Principal Financial Officer - Rule 13a-14(a)                Certification |
|--------|------|-----------------------------------------------------------------------------------------------------------|
|   |   |   |
|--------|--------|--------|

|   | 32.1 | Certification                of Principal Executive Officer and Principal Financial Officer -                Sarbanes-Oxley Act Section 906 Certification |
|--------|------|-----------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | UNIVERCELL                  HOLDINGS, INC.             |
|--------|--------------------------------------------------------|
|   |                                                   |
|   |                                                   |
|   |                                                   |
|   |                                                   |
|   | By:                  /S/ SEAN Y. FULDA                 |
|   | Sean                  Y. Fulda                         |
|   | Chief                  Executive Officer and President |
|   | Chief                  Financial Officer               |

----